April 12, 2025 01:08 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
15 flights diverted, many delayed as dust storm hits Delhi, Haryana | AIADMK, BJP join hands again to contest Tamil Nadu elections under Edappadi K Palaniswami | PM Modi inaugurates Rs. 3,880-cr projects in Varanasi on 50th visit to his Lok Sabha constituency | Bengal job losers camp outside SSC office in Kolkata, demand mirror copies of genuine candidate list | Mumbai terror attack accused Tahawwur Rana sent to 18-day NIA custody | Donald Trump's latest tariff hike on Beijing brings additional rate on some Chinese goods to 145 pct: White House | Pakistan distances itself from 26/11 terror accused Tahawwur Rana, says he is 'Canadian national' | Tahawwur Rana’s extradition proof of Modi govt's diplomatic strength: Amit Shah | Adult unmarried parents can live together without marriage: Allahabad High Court | Bengal job losers hold massive rally in Kolkata protesting over police assault
WHO backs Regeneron COVID-19 drug cocktail - with equal access, price cut

WHO backs Regeneron COVID-19 drug cocktail - with equal access, price cut

Sep 25, 2021, at 04:29 pm

New York: The Regeneron antibody drug cocktail – casirivimab and imdevimab – has been added to the World Health Organization’s (WHO) list of treatments for COVID-19 patients, the UN agency said on Friday, before underscoring the need for lower prices and equitable distribution.

Close menu